Latest Sunitinib Stories
By Barry Nelson A PROFESSOR who successfully "declared war" on cancer in France has urged the British Government to give more priority to the disease.
COLLEGEVILLE, Pa., May 31 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , today announced results of a three-arm phase 3 clinical trial that show patients with relapsed and/or refractory mantle cell lymphoma (MCL), a form of non-Hodgkin's lymphoma, treated with the mTOR (mammalian target of rapamycin) inhibitor TORISEL(R) (temsirolimus) experienced a statistically significant improvement in median progression-free survival (PFS), compared with single-agent therapy...
Please read in fourth paragraph ... "24 weeks from 12 weeks" ... instead of ...
By Toni Clarke ATLANTA (Reuters) - A kidney cancer drug made by Bayer AG and Onyx Pharmaceuticals Inc. showed promise in a small lung cancer trial, according to data released on Sunday, further fueling competition with a drug from Pfizer Inc.
By Toni Clarke ATLANTA (Reuters) - For the first time in decades there are new treatments available for kidney cancer, and as more data emerges about their efficacy, the competition looks set to heat up.
By Toni Clarke ATLANTA (Reuters) - Wyeth said on Sunday that interim results of a late-stage trial of its experimental kidney cancer drug significantly increased survival in patients compared to standard therapy.
By Ransdell Pierson NEW YORK (Reuters) - Pfizer Inc.'s kidney cancer drug Sutent will soon become the favored first-line treatment for advanced forms of the disease, based on its ability to prolong survival in a late-stage trial described on Sunday, researchers said.
By Toni Clarke ATLANTA (Reuters) - Using combinations of "smart bomb" cancer drugs that target specific proteins and avoid the indiscriminate cell destruction of chemotherapy may be the wave of the future for cancer patients, experts say.
A Pfizer Inc. kidney cancer drug has also shown promise in a small mid-stage trial as a treatment for the most common form of lung cancer, researchers said on Saturday.
By Susan Heavey WASHINGTON (Reuters) - The U.S. Food and Drug Administration approved a new drug to treat the most common type of kidney cancer on Tuesday, hailing it as a major advance in slowing tumor growth.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.